Vygon Group Acquires Perouse Medical

July 6, 2015—Vygon Group announced the acquisition of Perouse Medical, which designs, manufactures, and markets cardiovascular medical devices and long-term vascular access devices. The combination will allow Vygon to develop new, single-use health product families, with a focus on interventional cardiology and the treatment of cardiovascular diseases.

Vygon Group is a family company founded in 1962 with headquarters in Ecouen in the Greater Paris region of France. Perouse Medical, which was established in 1984, has offices in Ivry-le-Temple and Irigny, France.

As noted in the announcement, Vygon Group designs, manufactures, and markets high-tech, single-use medical devices for health care professionals in hospital and for private and independent practitioners. Vygon offers a wide range of products in a number of clinical specialties, including neonatology, adult and pediatric critical care, anesthesia, oncology, emergency, surgery, and home care.

Perouse products include stents, vascular grafts and patches, radial compression and inflation systems, hemostatic valves, angiographic syringes, as well as consumables for contrast media injectors for scanners and magnetic resonance imaging. Perouse’s long-term vascular access devices include implantable ports, peripherally inserted central catheters, Huber needles, and catheter maintenance dressings.

Thomas Walter, the current deputy director general of Perouse Medical, will be responsible for the general management of the company and will join the Vygon Group Executive Committee. The financial terms of the agreement were not disclosed.